Who owns Novavax?

Key details on Novavax (Ticker: NVAX)

Who owns Novavax?

Is NVAX a good stock to own? Find out who bought Novavax, who sold Novavax (NVAX) stock, and who holds a large position in Novavax.

Fund Name Number of Shares Share Valuation As Of
FMR 40.44M $339.33M Dec. 31, 2015
T. Rowe Price Associates 22.74M $190.78M Dec. 31, 2015
Vanguard 18.02M $151.17M Dec. 31, 2015
First Trust Advisors 13.53M $113.48M Dec. 31, 2015
BlackRock Fund Advisors 9.98M $83.72M Dec. 31, 2015
Wellington Management Company 8.86M $74.36M Dec. 31, 2015
STATE STREET CORPORATION 8.79M $73.77M Dec. 31, 2015
BB Biotech AG 8.33M $69.89M Dec. 31, 2015
Inves 8.14M $68.32M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 6.59M $55.29M Dec. 31, 2015
Damian Sousa 5.24M $27.05M March 31, 2016
Camber Capital Management 4.75M $19.81M Sept. 30, 2014
HealthCor Management 4.60M $23.55M Dec. 31, 2013
BNP PARIBAS INVESTMENT PARTNERS S.A. 3.80M $22.53M Dec. 31, 2014
Wells Fargo & Company 3.38M $23.92M Sept. 30, 2015
Ameriprise Financial 3.33M $27.96M Dec. 31, 2015
NORTHERN TRUST 3.24M $27.20M Dec. 31, 2015
RA Capital Management 3.24M $19.22M Dec. 31, 2014
Franklin Resources 3.04M $25.53M Dec. 31, 2015
Janus Capital Management 2.98M $25.03M Dec. 31, 2015
BlackRock Advisors 2.93M $6.01M June 30, 2013
Ayer Capital Management 2.77M $5.24M Dec. 31, 2012

Who sold Novavax?

Fund Name Date Sold Number of Shares Sold Share Valuation
VHCP Management Dec. 31, 2010 4.56M $11.07M